Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT120 in Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
NCT05091541Phase 2Not yet recruiting
- Sponsor
- Reindeer Biotech
- Start
- Oct 2021
- Primary completion
- Oct 2024
- Modality
- Autologous CAR-T
01
Overview
A Phase 2 trial of CT120 in B-cell non-Hodgkin lymphoma, sponsored by Reindeer Biotech. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
CT120
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05091541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05091541.